Description of the workplace

The position is based at Lund University’s Faculty of Medicine, within the Department of Experimental Medical Sciences, specifically the Medical Structural Biology research unit. The division focuses on uncovering molecular mechanisms of health and disease through advanced imaging and biophysical approaches.

The research group hosting this position studies Contractile Injection Systems (CIS) — natural protein machines used by bacteria to deliver molecular cargo. The group's mission is to understand the structure, function, and application of CIS for use in both biopesticide development and targeted antimicrobial delivery. The team is interdisciplinary, with expertise in molecular microbiology, structural biology, bioinformatics, and protein engineering, and currently includes the PI, a PhD student, and a research expert in bioinformatics.

The workplace fosters strong international collaboration, with close integration with the Halberg Group at Copenhagen University (Insect neuroendocrinology and physiology) and the Collin Group (immune-relevant enzymology and translational infection research) at Lund University. The postdoctoral researcher will work primarily in Lund but is expected to engage in frequent collaborative work across the Öresund region, including regular experimental coordination with Copenhagen-based researchers and data collection at national facilities such as MAX IV (Lund), SciLifeLab (Stockholm), and CFIM (Copenhagen), where cryo-electron microscopy (cryo-EM) and tomography (cryo-ET) are performed.

The group values a collegial and supportive research environment, with open communication, structured mentoring, and a strong emphasis on work-life balance. Lund University provides an excellent infrastructure for interdisciplinary and early-career research development.

Description of the AMBER project context

This post-doctoral position is part of the EU cofund research project AMBER, Advanced Multiscale Biological imaging using European Research infrastructures, will address scientific and sectoral gaps in biological imaging ranging from molecular, through cellular, to tissue, organ and organism levels of organisation, and is coordinated by LINXS Institute of advanced Neutron and X-ray Science.

AMBER is funded by the EU Marie Skłodowska-Curie (MSCA) COFUND scheme.

Around 15 postdocs will be recruited in the fifth call 2026, with each fellowship lasting 36 months.

AMBER has six core partners: Lund University/MAX IV, Sweden, the European Spallation Source (ESS), Sweden, the European Molecular Biology Laboratory (EMBL), Institut Laue-Langevin (ILL), France, the International Institute of Molecular Mechanisms and Machines, (IMOL), Poland, and the Leicester Institute of Structural and Chemical Biology, United Kingdom.

Your work may include clinical and biomedical projects. It may also include technique development work aimed at combining imaging techniques and data analysis to provide a more integrated picture of life processes in the context of health and disease. To be a postdoc fellow at the AMBER programme you will get unprecedented medical, biological, and methodological capabilities, with a profound potential impact for Europe’s next generation of research and researchers. When you have completed the AMBER programme you will be extraordinarily well equipped to further your career in academia, at infrastructures, in the health and MedTech sectors, and beyond.

For more information about the total announced post-doctoral positions within in the AMBER co-fund project please visit https://www.euraxess.se/jobs/392999.

The interviews will start in April/May 2026. For more information about AMBER, application and evaluation process etc please visit: ambercofund.eu